Five notes:
1. Worldwide revenue was $40.3 million in the third quarter, a 19% increase year over year.
2. U.S. revenue was $38.3 million, an 18% increase year over year.
3. The company saw a net loss of $6.6 million.
4. There are more than 1,200 physicians in the U.S. using SI-Bone’s products in the third quarter, a 15% increase year over year.
5. SI-Bone also refinanced a $36 million term loan, lowered all-in borrowing costs and extended maturity to 2029.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
